SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-005371
Filing Date
2024-02-08
Accepted
2024-02-08 07:30:10
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5683
  Complete submission text file 0001493152-24-005371.txt   7436
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 24606864

Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)